Breast Milk News and Research RSS Feed - Breast Milk News and Research

Support from lactation consultant improves chances of breastfeeding

Support from lactation consultant improves chances of breastfeeding

In two separate clinical trials, researchers at Albert Einstein College of Medicine of Yeshiva University have found that periodic meetings with a lactation consultant encourages women traditionally resistant to breastfeeding to do so, at least for a few months-long enough for mother and child to gain health benefits. The results of the trials were published online today in American Journal of Public Health. [More]
Physicians study mothers' breast milk to determine correct amounts of nutrients for premature infants

Physicians study mothers' breast milk to determine correct amounts of nutrients for premature infants

Physicians in the Neonatal Intensive Care Unit in the Maxine Dunitz Children's Health Center launched a pilot study in which mothers' breast milk is analyzed to determine whether premature infants are receiving the correct amounts of nutrients they need to thrive. [More]
Periodic meetings with lactation consultant improves chances of breastfeeding

Periodic meetings with lactation consultant improves chances of breastfeeding

In two separate clinical trials, researchers at Albert Einstein College of Medicine of Yeshiva University have found that periodic meetings with a lactation consultant encourages women traditionally resistant to breastfeeding to do so, at least for a few months—long enough for mother and child to gain health benefits. [More]
Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Janssen Research & Development, LLC (Janssen) today announced it has received from the U.S. Food and Drug Administration (FDA) a complete response letter regarding its New Drug Application (NDA) for a fixed-dose combination (FDC) of canagliflozin and immediate-release metformin to treat adults with type 2 diabetes. [More]
Infants likely becoming exposed to potentially harmful substances via PCPs

Infants likely becoming exposed to potentially harmful substances via PCPs

Through lotions, shampoos and other personal care products (PCPs), infants and toddlers are likely becoming exposed to potentially harmful substances, called parabens, at an even higher level than adult women in the U.S., researchers have reported. [More]
Population Council partners with USAID to introduce new line of contraceptive rings

Population Council partners with USAID to introduce new line of contraceptive rings

The Population Council was awarded a cooperative agreement from the U.S. Agency for International Development's Office of Population and Reproductive Health, "Delivering a Family of Contraceptive Vaginal Rings." Included in this agreement is support for two innovative, Population Council-developed contraceptive vaginal rings: a one-year contraceptive vaginal ring that can be used by women to plan their pregnancies and a three-month vaginal ring that can be used by breastfeeding women. [More]
New findings on effects of epilepsy on mother and child

New findings on effects of epilepsy on mother and child

New research pertaining to the latest findings on the effects of epilepsy on both the mother and child were presented at the American Epilepsy Society's 67th Annual Meeting in Washington DC. These studies explore folic acid use, the effect of surgery with intractable focal epilepsy, and antiepileptic drug exposure during breastfeeding. [More]

UNICEF, WHO support breastfeeding to avoid illness and deaths of children in Philippines

UNICEF and WHO today called on those involved in the response to the Philippines' Typhoon Haiyan (Yolanda) disaster to promote and protect breastfeeding to avoid unnecessary illness and deaths of children. [More]
WHO releases new treatment guidelines for children suffering severe acute malnutrition

WHO releases new treatment guidelines for children suffering severe acute malnutrition

WHO today released new treatment guidelines for the almost 20 million children under-five worldwide who have severe acute malnutrition. [More]
FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration has approved OLYSIO (simeprevir), an NS3/4A protease inhibitor, for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with pegylated interferon and ribavirin in genotype 1 infected adults with compensated liver disease, including cirrhosis. [More]
Research: Introducing solid food with breast milk could reduce food allergies in babies

Research: Introducing solid food with breast milk could reduce food allergies in babies

Introducing solid food with breast milk after the 17th week of birth could reduce food allergies in babies, according to University of Southampton research. [More]
Study on women's preferences, decision-making patterns regarding treatment for depression during, after pregnancy

Study on women's preferences, decision-making patterns regarding treatment for depression during, after pregnancy

Women with depression in the perinatal period experience a high degree of conflict in deciding whether and how to treat their depression, but strongly prefer treatments other than antidepressant medications, reports a study in the November Journal of Psychiatric Practice®. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. [More]
Study: Increased duration of breastfeeding could be associated with decreased incidence of autism

Study: Increased duration of breastfeeding could be associated with decreased incidence of autism

In an article appearing in Medical Hypotheses on September 20, a New York-based physician-researcher from the Touro College of Osteopathic Medicine has called for the testing of umbilical cord blood for levels of a growth protein that could help predict an infant's propensity to later develop autism. [More]
Phase 3 study shows STELARA inhibits structural damage in patients with active psoriatic arthritis

Phase 3 study shows STELARA inhibits structural damage in patients with active psoriatic arthritis

​New findings from two integrated Phase 3 Janssen Research & Development, LLC (Janssen)-sponsored studies showed treatment with STELARA- (ustekinumab) resulted in significantly greater inhibition of structural damage in patients with active psoriatic arthritis compared with placebo. [More]
Breast milk may protect babies from acquiring HIV infection, say researchers

Breast milk may protect babies from acquiring HIV infection, say researchers

A substance in breast milk that neutralizes HIV and may protect babies from acquiring HIV from their infected mothers has been identified for the first time by researchers at Duke Medicine. [More]
Breast milk purchased over Internet contained bacteria that can cause illness in infants

Breast milk purchased over Internet contained bacteria that can cause illness in infants

Results from a study led by researchers at Nationwide Children's Hospital found more than three-fourths of breast milk samples purchased over the Internet contained bacteria that can cause illness, and frequently exhibited signs of poor collection, storage or shipping practices. [More]
Breastfeeding and personality: an interview with Dr Amy Brown

Breastfeeding and personality: an interview with Dr Amy Brown

In the UK we've got quite a problem with breastfeeding. The government recommends that all women should breastfeed for six months, exclusively just breast milk, and then for up to a year and beyond. But quite a few women struggle in the UK. About 80% initiate breastfeeding but that drops off really quickly. [More]
FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) alone or in combination with methotrexate for the treatment of adult patients (18 years or older) with active psoriatic arthritis. [More]
Phase III EINSTEIN trial program: XARELTO reduces risk of DVT and PE

Phase III EINSTEIN trial program: XARELTO reduces risk of DVT and PE

Janssen Pharmaceuticals, Inc. announced today a newly published, pooled analysis of the Phase III EINSTEIN trial program, showing XARELTO (rivaroxaban) is as effective as the standard of care in reducing the risk of deep vein thrombosis and pulmonary embolism in people with symptomatic DVT or PE, while reducing the incidence of major bleeding by 46 percent. [More]
Oxytocin shows evidence of therapeutic value for autism, schizophrenia

Oxytocin shows evidence of therapeutic value for autism, schizophrenia

The hormone oxytocin could play a role in treating psychiatric disorders such as autism and schizophrenia, according to a review article in the September Harvard Review of Psychiatry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. [More]